The Discounted Cash Flow (DCF) valuation of StageZero Life Sciences Ltd (SZLS.TO) is (3.72) CAD. With the latest stock price at 0.04 CAD, the upside of StageZero Life Sciences Ltd based on DCF is -9400.0%.
Based on the latest price of 0.04 CAD and our DCF valuation, StageZero Life Sciences Ltd (SZLS.TO) is a sell. selling SZLS.TO stocks now will result in a potential gain of 9400.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.4% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (12.73) - (2.23) | (3.72) |
| Upside | -31934.7% - -5677.7% | -9400.0% |